Jim Cramer on Abbott: “I Think It’s a Terrific Time to Do Some Buying”

“This morning, Abbott Labs announced that it’s buying Exact Sciences, that’s the colorectal crab screening company, for astir $21 billion. It’s a 51% premium wherever it was trading earlier we started proceeding speech of the deal. This transaction volition beryllium the largest healthcare woody successful 2 years and the largest diagnostic acquisition ever. Exact Sciences has a large product… Of course, this benignant of woody astir apt would’ve been blocked by Biden’s antitrust regulators if lone due to the fact that the FTC nether Lina Khan seemed reflexively hostile to each mergers. But nether Trump, it’ll astir apt sail through.

Courtesy of Abbott Labs

Abbott Laboratories (NYSE:ABT) develops and sells healthcare products, including generic medicines, diagnostic systems, nutrition brands, cardiovascular and diabetes attraction devices, and neuromodulation technologies.

While we admit the imaginable of ABT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.